An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer

Authors: Yue Kuai, Hao Liu, Dongyu Liu, Yunlong Liu, Ye Sun, Jiansheng Xie, Jiachun Sun, Yong Fang, Hongming Pan, Weidong Han

Published: 2020-06-15

DOI: 10.7150/thno.43938

Source: Full article

---

Abstract

No abstract found.